Target intelligence / Profile preview

Scavenger receptor class F member 1 (SREC-I) (SCARF1)

Target
SCARF1
Molecular classification
Scavenger receptor, Receptor, Type I transmembrane protein
01

Overview

Scavenger receptor class F member 1 (SREC-I), also known as SCARF1, is a type I transmembrane protein that functions as a scavenger receptor on endothelial cells and antigen-presenting cells (APCs) such as dendritic cells and macrophages (UniProt Q9UHF0). It plays a pivotal role in the immune system by mediating the uptake of a wide range of ligands, including acetylated low-density lipoproteins, heat shock proteins (HSPs), and apoptotic cells (PubMed: 17641034). On APCs, SREC-I is particularly important for its ability to bind HSP-antigen complexes, facilitating their internalization and subsequent cross-presentation to CD8+ T cells, which is a critical step in generating anti-tumor immune responses (PubMed: 25108027). Furthermore, SREC-I is essential for efferocytosis, the process of clearing apoptotic debris; a deficiency in this receptor is linked to the development of systemic lupus erythematosus (SLE) due to the accumulation of autoantigens (PubMed: 21606508). In therapeutic development, SREC-I is targeted by investigational cancer vaccines, such as those using HSP70-peptide complexes, to enhance the delivery of tumor antigens to the immune system. It also serves as a potential entry point for various pathogens, including certain viruses and fungi, making it a target for research into anti-infective strategies.

Other names
SREC-ISREC1Scavenger receptor expressed on endothelial cells 1Acetyl-LDL receptor
02

Mechanism of action

SREC-I facilitates the binding and internalization of heat shock protein (HSP)-antigen complexes via receptor-mediated endocytosis, leading to the trafficking of antigens into the cross-presentation pathway for activation of CD8+ T cells.

03

Biological functions

Antigen cross-presentationEfferocytosisImmune response regulationEndocytosisSignal transduction
04

Disease associations

CancerSystemic lupus erythematosusAutoimmune diseaseInfectionAtherosclerosis
05

Safety considerations

Risk of autoimmune reactions due to impaired clearance of apoptotic cellsPotential for off-target inflammatory responsesPathogen exploitation for cellular entry (e.g., Hepatitis C virus)
06

Interacting drugs

Vitespen (HSPPC-96)

3 more in the full profile.

07

Biomarkers

SCARF1 expression on dendritic cellsSoluble SREC-I levels

Beyond the preview

Go deeper on Scavenger receptor class F member 1 (SREC-I) (SCARF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scavenger receptor class F member 1 (SREC-I) (SCARF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call